Table 2.

Demographic and baseline data of favourable and unfavourable outcome groups

	Favourable outcome, n=178 (%)	Unfavourable outcome, n=42 (%)	P value
Male	99 (55.6)	27 (64.3)	0.307
Age (${\displaystyle \overline{\mathrm{X}}\pm \mathrm{S}}$, years)	56.2±8.1	65.3±8.8	0.000
History of hyperlipidaemia	53 (29.8)	13 (31.0)	0.881
History of diabetes	38 (19.3)	15 (30.6)	0.084
History of coronary heart disease	7 (3.9)	2 (4.8)	0.682*
History of atrial fibrillation	0 (0)	1 (2.4)	0.191*
History of stroke	3 (1.7)	5 (11.9)	0.007*
Smoking	90 (50.6)	26 (61.9)	0.185
Alcohol abuse	62 (34.8)	19 (46.3)	0.169
Hypotension	130 (73.0)	29 (69.0)	0.604
Warfarin treatment	8 (4.5)	4 (9.5)	0.250*
SBP (${\displaystyle \overline{\mathrm{X}}\pm \mathrm{S}}$, mm Hg)	162.9±22.8	164.5±24.2	0.535
DBP (${\displaystyle \overline{\mathrm{X}}\pm \mathrm{S}}$, mm Hg)	103.7±9.1	104.9±9.3	0.674
ICH location, n (%)
Basal ganglia	95 (53.4)	21 (50.0)	0.694
Thalamus	68 (38.2)	19 (45.2)	0.402
Lobar	15 (8.4)	2 (4.8)	0.538*
Baseline ICH volume, median (IQR), mL	30 (21–39)	33 (22–38)	0.035
ICH score, median (IQR)	2 (0–3)	2 (1–3)	0.316
IVH presence	26 (14.6)	13 (31.0)	0.013
Midline shift	145 (81.5)	37 (88.1)	0.306
Admission GCS, median (IQR)	11 (9–14)	10 (9–13)	0.038
Haemoglobin (${\displaystyle \overline{\mathrm{X}}\pm \mathrm{S}}$, g/L)	108.7±13.4	105.3±13.2	0.332
Blood glucose, median (IQR)	7.4 (6.2–8.7)	8.9 (6.8–11.2)	0.027
INR, median (IQR)	1.1 (0.7–1.3)	1.2 (0.8–1.4)	0.152
Onset to the first CT time (min, ${\displaystyle \overline{\mathrm{X}}\pm \mathrm{S}}$)	182.7±53.3	181.8±53.4	0.627
Onset to admission time (min, ${\displaystyle \overline{\mathrm{X}}\pm \mathrm{S}}$)	165.18±51.4	165.7±50.5	0.884
Treatment plan, n (%)			0.000
Stereotactic aspiration	126 (88.7)	16 (11.3)
Conservative treatment	52 (70.8)	26 (38.1)

*Fisher’s exact test.

DBP, diastolic blood pressure, 1 mm Hg=0.133 kPa; GCS, Glasgow Coma Scale; ICH, intracerebral haemorrhage; INR, International normalised ratio; IVH, intraventricular haemorrhage; SBP, systolic blood pressure.